ESALY Eisai Co. Ltd. Sponsored ADRs
Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4523.
This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.
$13.74 Pink
As of 03/23/2023 OTCMarkets
Security Information
Category1: US Equity
Category2: ADRs
Category3: Large cap
GICS sector: Health Care
Industry: Drug Manufacturers—Specialty &
Index country: Japan
Country of incorporation: Japan
IPO date: 12/01/1995
Outstanding shares: 296,566,949
Average volume: 34,201
Market cap: $18,241,833,033
Current dividend yield: 0.00%
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 0.00
PS ratio: 0.00
Return on equity: 0.00%
Net income %: 0.00%